Prognostic and predictive molecular markers in cholangiocarcinoma
S Pavicevic, S Reichelt, D Uluk, I Lurje, C Engelmann… - Cancers, 2022 - mdpi.com
Simple Summary Cholangiocarcinoma (CCA) is a heterogenous and aggressive
malignancy of the intra-and extrahepatic biliary tract, marked by a steeply rising incidence …
malignancy of the intra-and extrahepatic biliary tract, marked by a steeply rising incidence …
[HTML][HTML] Role of routine lymph node dissection alongside resection of intrahepatic cholangiocarcinoma: Systematic review and meta-analysis
M Atif, A Borakati, VK Mavroeidis - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND The global incidence of intrahepatic cholangiocarcinoma (ICCA) is soaring.
Due to often delayed presentation, only a narrow spectrum of the disease is usually …
Due to often delayed presentation, only a narrow spectrum of the disease is usually …
Dual-energy CT based material decomposition to differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma
S Mahmoudi, S Bernatz, FC Althoff, V Koch… - European journal of …, 2022 - Elsevier
Purpose To assess the potential of material decomposition in dual-energy CT (DECT) to
differentiate intrahepatic cholangiocarcinoma (iCCA) from hepatocellular carcinoma (HCC) …
differentiate intrahepatic cholangiocarcinoma (iCCA) from hepatocellular carcinoma (HCC) …
Interventional treatment strategies in intrahepatic cholangiocarcinoma and perspectives for combined hepatocellular-cholangiocarcinoma
TA Auer, F Collettini, L Segger, U Pelzer, R Mohr… - Cancers, 2023 - mdpi.com
Simple Summary Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare form
of liver cancer with features of both hepatocellular and biliary tract cancer. Locoregional …
of liver cancer with features of both hepatocellular and biliary tract cancer. Locoregional …
Development and validation of a machine-learning model to predict early recurrence of intrahepatic cholangiocarcinoma
Background The high incidence of early recurrence after hepatectomy for intrahepatic
cholangiocarcinoma (ICC) has a detrimental effect on overall survival (OS). Machine …
cholangiocarcinoma (ICC) has a detrimental effect on overall survival (OS). Machine …
Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines
S Janthamala, B Promraksa, M Thanee… - … Medicine and Therapies, 2024 - Springer
Background Gastrointestinal cancer (GIC) ranks as the highest cause of cancer-related
deaths globally. GIC patients are often diagnosed at advanced stages, limiting effective …
deaths globally. GIC patients are often diagnosed at advanced stages, limiting effective …
Hu antigen R (HuR) protein structure, function and regulation in hepatobiliary tumors
S Lachiondo-Ortega, TC Delgado, B Baños-Jaime… - Cancers, 2022 - mdpi.com
Simple Summary Hepatobiliary tumors are a group of primary malignancies encompassing
the liver, the intra-and extra-hepatic biliary tracts, and the gall bladder. Within the liver …
the liver, the intra-and extra-hepatic biliary tracts, and the gall bladder. Within the liver …
A cuproptosis-related gene expression signature predicting clinical prognosis and immune responses in intrahepatic cholangiocarcinoma detected by single-cell RNA …
H Ren, C Liu, C Zhang, H Wu, J Zhang, Z Wang… - Cancer Cell …, 2024 - Springer
Background Cholangiocarcinoma represents a malignant neoplasm originating from the
hepatobiliary tree, with a subset of tumors developing inside the liver. Intrahepatic …
hepatobiliary tree, with a subset of tumors developing inside the liver. Intrahepatic …
Computed tomography radiomics to differentiate intrahepatic cholangiocarcinoma and hepatocellular carcinoma
S Mahmoudi, S Bernatz, J Ackermann, V Koch… - Clinical Oncology, 2023 - Elsevier
Aims Intrahepatic cholangiocarcinoma (iCCA) and hepatocellular carcinoma (HCC) differ in
prognosis and treatment. We aimed to non-invasively differentiate iCCA and HCC by means …
prognosis and treatment. We aimed to non-invasively differentiate iCCA and HCC by means …
Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma
S Deng, X Lu, X Wang, B Liang, H Xu, D Yang… - Cell Death & …, 2024 - nature.com
TBX3 behaves as a tumor suppressor or oncoprotein across cancer. However, TBX3
function remains undetermined in intrahepatic cholangiocarcinoma (iCCA), a deadly primary …
function remains undetermined in intrahepatic cholangiocarcinoma (iCCA), a deadly primary …